Plasmids expressing different domains of hUpf or EJC proteins were constructed by subcloning the corresponding cDNA sequences into a pcDNA3-Myc vector described (Figs. 2C, 6 , and S1) were introduced using overlapping PCR. To obtain the 3xhUpf3b 1-143 expression plasmids (Fig. 3B) , the hUpf3b 1-143 cDNA sequence was generated by PCR with an upstream NheI site and a downstream XbaI site and inserted in triplicate into the XbaI site of pcDNA3-Myc or pcDNA3-Myc-NLS, which contains the SV40 large T-antigen NLS immediately downstream of the Myc-tag. The plasmids expressing fulllength EJC proteins (Fig. 5A) were either described earlier (Lykke-Andersen et al., 2001) or constructed by inserting full-length cDNA sequences into the pcDNA3-Myc
vector (Barentsz: XbaI and NotI; eIF4AIII: BamHI and NotI; Magoh: EcoRI and NotI).
The hnRNP C1 cDNA sequences corresponding to amino acids 88-165 (NRS) or 98-144 (mutNRS) were inserted upstream of the hUpf1 cDNA sequence in HindIII and BamHI sites in the pcDNA3 Myc-hUpf1 R plasmid, which was derived from pcDNA3 MychUpf1 described earlier (Lykke-Andersen, 2002 ) by mutating wobble positions at amino acids K627 (G-to-A) and R631 (C-to-A) by site-directed mutagenesis (QuickChange, Stratagene) . This ensures resistance to the hUpf1 siRNA used in Figure 4 . The construct for knock-down of hUpf1 (pSHAG-hUpf1) is based on the pSHAG plasmid (a gift from Dr. Gregory Hannon), and contains an insert expressing a precursor to a hUpf1 siRNA described earlier (Mendell et al., 2002) . pGEX4T1-hUpf3b plasmid for expression and purification of GST-hUpf3b protein was described earlier (Lykke-Andersen et al., 2000) . pcDNA3-GST-GFP plasmid used in in vitro binding assays ( (Clontech), respectively. In pPC-GPx1-UAA the seleno-cysteine UGA codon (codon-46) was then mutated to UAA using overlapping PCR. A plasmid to generate an anti-sense RNA probe for TCR-β (pcDNA3-TCR-β-LVβ 8.1 ) was constructed by inserting in reverse orientation the leader exon, the variable exon and the intervening intron from plasmid pβ299 (a gift from Dr. Miles Wilkinson) into BamHI and NotI sites of pcDNA3.
Analysis of TCR-β Steady-State mRNA Levels
For steady state analysis of TCR-β-68 mRNA levels ( Fig. S8 ), HeLa Tet-off cells in 3.5-cm plates were co-transfected with 0.5 µg of pβ367 (a gift from Dr. Miles Wilkinson), 10 ng of pcβwt and 1.5 µg of plasmids expressing hUpf-interaction domains or pcDNA3-hUpf1-R844C. ~48 hours post-transfection, total cellular RNA was isolated and analyzed by Northern blots as described earlier (Lykke-Andersen et al., 2000) . An
antisense RNA probe to detect TCR-β mRNAs was in vitro transcribed from a linearized plasmid template (pcDNA3-TCR-β-LVβ 8.1 linearized with NotI) using the Strip-EZ RNA-SP6 kit (Ambion) and α 32 P-UTP.
Anti-FLAG In Vitro Pull-Down Assays
For in vitro pull-down assays between FLAG-tagged hUpf proteins and in vitro translated fragments of NMD proteins (Fig. S4) or NRS-fusions of hUpf1 (Fig. S9 ), FLAG-tagged proteins were purified from HEK293T cells as described earlier (LykkeAndersen, 2002) except that cell lysates were supplemented with 800mM NaCl. In vitro pull-down assays with FLAG-tagged proteins immobilized on anti-FLAG agarose beads were subsequently carried out as described in the Experimental Procedures section. 
Figure S4. NLS Modifications Do Not Affect the Interactions of the Inhibitory Polypeptides with Full-Length NMD Factors
Anti-FLAG pull-down assays between FLAG-tagged proteins pre-purified from HEK293T cells (FLAG-MS2, lanes 7-12; FLAG-hUpf3b (A) or FLAG-hUpf2 (B), lanes 13-18) and subsequently incubated with the in vitro translated Myc-tagged proteins indicated on top of each lane. Lanes 1-6: 5% input. Lanes 7-18: pull-down fractions. The migration of the in vitro translated Myc-tagged proteins and the negative control, Myc hnRNP A1, are indicated on the left. hUpf3b could not be tested in this assay because it is unknown which EJC factor it binds to directly. Anti-FLAG pull-down assays between FLAG-hUpf2 protein pre-purified from HEK293T cells and subsequently incubated with in vitro translated 35 S-labelled (from reticulocyte lysates) Myc-tagged proteins indicated on the top of each lane. Lanes 1-3: 5% input. Lanes 4-6: pull-down fractions. In vitro translated Myc-tagged hnRNP A1 was used as a negative control in each reaction.
